Volume 28, Number 12—December 2022
Research
Observational Cohort Study of Evolving Epidemiologic, Clinical, and Virologic Features of Monkeypox in Southern France
Table 3
Variable | Positive samples/total (%) | Mean Ct (SD) |
---|---|---|
PCR results | ||
Skin swabs | 69/84 (82) | 28.3 (4.7) |
Genital swabs | 67/69 (97) | 26.2 (4.0) |
Throat swabs | 50/116 (43) | 32.2 (3.4) |
Rectal swabs |
68/105 (65) |
26.1 (5.2) |
Concurrent STIs | ||
HIV | 2/9 (22.2) | NA |
Chlamydia trachomatis | 4/127 (3.1) | NA |
Neisseria gonorrhoeae | 13/127 (10.2) | NA |
Mycoplasma genitalium | 1/127 (0.8) | NA |
Syphilis | 4/127 (3.1) | NA |
Trichomonas vaginalis | 1/127 (0.8) | NA |
Other STIs | 19/127 (15) | NA |
*Ct, cycle threshold; STI, sexually transmitted infection; NA, not applicable.
Page created: October 04, 2022
Page updated: November 21, 2022
Page reviewed: November 21, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.